SFM
LLY icon

Signet Financial Management’s Eli Lilly LLY Stock Holding History

Signet Financial Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.43M Sell
10,249
-441
-4% -$447K 1.06% 22
2025
Q4 		$11.5M Buy
10,690
+40
+0.4% +$38.2K 1.28% 12
2025
Q3 		$8.13M Buy
10,650
+21
+0.2% +$15.6K 0.94% 25
2025
Q2 		$8.29M Sell
10,629
-73
-0.7% -$56.7K 1.04% 23
2025
Q1 		$8.84M Buy
10,702
+104
+1% +$86.5K 1.19% 14
2024
Q4 		$8.18M Sell
10,598
-20
-0.2% -$16.6K 1.04% 22
2024
Q3 		$9.41M Buy
10,618
+71
+0.7% +$63.8K 1.2% 15
2024
Q2 		$9.55M Sell
10,547
-88
-0.8% -$70.4K 1.29% 15
2024
Q1 		$8.27M Buy
10,635
+168
+2% +$120K 1.14% 18
2023
Q4 		$6.1M Buy
10,467
+52
+0.5% +$30.4K 0.91% 26
2023
Q3 		$5.59M Sell
10,415
-235
-2% -$121K 0.92% 24
2023
Q2 		$4.99M Sell
10,650
-3
-0% -$1.26K 0.79% 27
2023
Q1 		$3.66M Sell
10,653
-10,105
-49% -$3.41M 0.62% 47
2022
Q4 		$7.59M Sell
20,758
-202
-1% -$71.6K 1.36% 12
2022
Q3 		$6.78M Buy
20,960
+189
+0.9% +$59.9K 1.33% 12
2022
Q2 		$6.74M Buy
20,771
+132
+0.6% +$39.6K 1.28% 14
2022
Q1 		$5.91M Buy
20,639
+169
+0.8% +$43.5K 0.99% 22
2021
Q4 		$5.65M Buy
20,470
+81
+0.4% +$20.5K 0.86% 27
2021
Q3 		$4.71M Buy
+20,389
New +$5.03M 0.81% 33
2021
Q2 		– Sell
-20,859
Closed -$3.9M – 186
2021
Q1 		$3.9M Sell
20,859
-128
-0.6% -$25K 0.73% 36
2020
Q4 		$3.54M Sell
20,987
-839
-4% -$125K 0.72% 37
2020
Q3 		$3.24M Sell
21,826
-903
-4% -$140K 0.72% 37
2020
Q2 		$3.48M Sell
22,729
-2,583
-10% -$396K 0.77% 37
2020
Q1 		$3.99M Sell
25,312
-3,384
-12% -$465K 0.94% 26
2019
Q4 		$3.77M Sell
28,696
-529
-2% -$61.3K 0.7% 50
2019
Q3 		$3.3M Sell
29,225
-13,117
-31% -$1.46M 0.65% 56
2019
Q2 		$4.58M Sell
42,342
-3,986
-9% -$469K 0.91% 36
2019
Q1 		$5.49M Sell
46,328
-2,281
-5% -$277K 1.07% 25
2018
Q4 		$5.63M Buy
48,609
+1,088
+2% +$122K 1.23% 18
2018
Q3 		$5.1M Sell
47,521
-4
-0% -$400 0.89% 34
2018
Q2 		$4.05M Buy
47,525
+45,711
+2,520% +$3.75M 0.72% 56
2018
Q1 		$140K Buy
+1,814
New +$146K 0.03% 243
2017
Q2 		– Sell
-2,574
Closed -$216K – 193
2017
Q1 		$216K Sell
2,574
-1,550
-38% -$124K 0.05% 175
2016
Q4 		$303K Hold
4,124
– – 0.07% 142
2016
Q3 		$331K Hold
4,124
– – 0.08% 133
2016
Q2 		$325K Hold
4,124
– – 0.08% 136
2016
Q1 		$297K Buy
4,124
+1,500
+57% +$113K 0.06% 144
2015
Q4 		$221K Buy
+2,624
New +$218K 0.05% 180
2015
Q3 		– Sell
-2,676
Closed -$223K – 196
2015
Q2 		$223K Buy
+2,676
New +$204K 0.05% 166

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Signet Financial Management's LLY Position: Q1 2026 in Review

Signet Financial Management reduced its Eli Lilly (LLY) stake by 4.1% in Q1 2026, selling an estimated $447K and leaving 10,249 shares worth $9.43M. The position accounts for 1.06% of the portfolio, ranked #22.

Signet Financial Management first reported a position in LLY in Q2 2015 and has held it in 39 quarters since. The position peaked at $11.5M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Signet Financial Management held 10,249 shares of Eli Lilly worth $9.43M as of Q1 2026.
  • Signet Financial Management sold 441 Eli Lilly shares in Q1 2026, an estimated $447K.
  • Eli Lilly made up 1.06% of Signet Financial Management's portfolio in Q1 2026, its #22 holding.
  • Signet Financial Management first reported a position in Eli Lilly in Q2 2015 and has held it in 39 quarters since.
  • Signet Financial Management's Eli Lilly position peaked at $11.5M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.